Modified glaucoma surgery after failed combined cataract and GATT
Part of Eyes & vision clinical trials.
This trial tests a modified trabeculectomy (a type of glaucoma surgery) for people whose earlier combined cataract and minimally invasive glaucoma surgery (GATT) did not work well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had cataract surgery combined with a glaucoma procedure called GATT.
- You must have had cataract surgery with a procedure called gonipuncture.
- You cannot be a healthy person without eye problems.
- You cannot have never had these specific eye surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, gentler cataract surgery method in people who have both glaucoma and cataracts. It aims to lower eye pressure safely during the procedure.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
This study tests a new tube-based surgery to lower eye pressure in people with advanced or difficult-to-treat open-angle glaucoma. The goal is to see if this surgery works better than standard care for controlling pressure and preserving vision.
This study looks at the long-term results of a specific glaucoma surgery (trabectome) done at one hospital. If you had this surgery there between 2019 and 2021, researchers want to check your eye health now to see how well it worked.
This trial studies a new tube-shunt surgery (SCTSC) against the standard trabeculectomy for people with open-angle glaucoma that is not controlled by eye drops. It is only for people who have already had cataract surgery.
This trial tests a surgery called GATT combined with goniosynechiolysis to treat glaucoma patients whose eye drainage angle is closed due to scarring. It aims to lower eye pressure when medicines alone aren't working.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.